← All trials
NCT05002179
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 20, 2020
- Primary completion
- May 29, 2021
- Completion date
- May 29, 2021
- First posted
- Aug 12, 2021
- Last posted
- Aug 12, 2021
- Enrollment
- 122
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- A. Vogel AGLead sponsor
- Medistat Ltd., IsraelCollaborator
- VITA HospitalOverall official - principal investigator
- Biodome ClinicalCollaborator
- BodimedCollaborator
- Clinical Research Centre CONVEXCollaborator
- d.s.h. statistical services GmbHCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.